BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 01, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

PPAR gamma agonist: Phase II start

This half, the New York Psychiatric Institute will begin a double-blind, U.S. Phase II trial to evaluate an oral PPAR gamma agonist from Omeros in 35 prescription opioid...

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >